We have recently demonstrated that SCLC tumors usually harbor inactive Notch signaling and that activation of Notch reduces expression of neuroendocrine genes (e.g., CHGA, SYP and NCAM1) and Ascl16. This evidence concerns the gene NCAM1 and small cell lung carcinoma.